Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
WEDNESDAY, Sept. 18, 2024 – For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and Parkinson disease...
Diabetes Complications Tied to Higher Risk for Gum Disease
THURSDAY, Sept. 19, 2024 – Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published online Aug. 5 in the Journal of Dental Research....
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19
THURSDAY, Sept. 19, 2024 – After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute...
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
TUESDAY, Sept. 17, 2024 – For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with...
Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
TUESDAY, Sept. 17, 2024 – Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 10 in BMJ Open Diabetes ...
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease
MONDAY, Sept. 16, 2024 – Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In...
Time-Restricted Eating Helps to Improve Diabetes Outcomes
FRIDAY, Sept. 13, 2024 – Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study presented at the annual meeting of the European Association...
Once-Weekly Efsitora Noninferior to Degludec for Type 2 Diabetes
FRIDAY, Sept. 13, 2024 – Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2 diabetes who have not received insulin, according to...
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
FRIDAY, Sept. 13, 2024 – For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent, dosage, treatment indication, and...
Exposure to Glucocorticoids Increases Risk for New-Onset Diabetes
WEDNESDAY, Sept. 11, 2024 – Exposure to systemic glucocorticoids during hospitalization is associated with an increased risk for new-onset diabetes, according to a study presented at the annual of...
Risk for T2D Increased for Individuals With Late Chronotype
WEDNESDAY, Sept. 11, 2024 – People with a late chronotype have an increased risk for type 2 diabetes (T2D) and have higher body mass index (BMI) and larger waist circumference, according to a study...
Diabetes Can Sometimes Lead to Gum Disease
WEDNESDAY, Sept. 11, 2024 – People with diabetes are more prone to gum disease, due to the damage the chronic illness does to small blood vessels, a new study warns. Diabetics who suffer from other...
Weekly Insulin Injections As Effective for Diabetes as Daily Shots, Studies Show
WEDNESDAY, Sept. 11, 2024 – Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called...
Reciprocal Relationship Identified Between T2D, Asthma
WEDNESDAY, Sept. 11, 2024 – There is a reciprocal relationship between asthma and type 2 diabetes (T2D), according to a study presented at the annual meeting of the European Association for the...
Asthma Risk Doubles in People With Diabetes
TUESDAY, Sept. 10, 2024 – People with type 2 diabetes are nearly twice as likely to develop asthma, a new review has concluded. Type 2 diabetics are 83% more likely to develop asthma, compared to...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Humalog, Farxiga, Lantus Solostar, Jardiance, Novolog, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, liraglutide, Levemir, Glucophage, Invokana, insulin degludec, Humulin N